Skip to Main Content

After a year-long battle, a federal judge ordered Novartis to turn over to the Department Justice documents containing details of allegedly 79,200 “sham” speaking events the drug maker used to encourage doctors to prescribe several blood pressure medicines.

The decision stems from a whistleblower lawsuit, which was initially filed six years ago by a former Novartis sales rep, contending the drug maker violated federal anti-kickback laws for nearly a decade. The Justice Department later joined the lawsuit, which alleged Novartis paid bribes to boost prescriptions and, as a result, caused federal health care programs to overpay for medicines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED